VIT 10.9% 8.2¢ vitura health limited

Ann: Psychedelic joint venture with PharmAla Biotech, page-8

  1. 59 Posts.
    lightbulb Created with Sketch. 2
    It means that whatever sale orders PharmaAla had at the signing of the letter of intent with VIT in February 2023, will be transferred to Cortexa (a JV owned 50:50 by VIT and PharmaAla) who will then continue to supply Australia with products for various clinical trials importing from Canada until facilities are set up in Oz for production here. Cortexa will therefore be supplying Australia via IHL et al.
    Last edited by anjiegee: 02/05/23
 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.010(10.9%)
Mkt cap ! $47.22M
Open High Low Value Volume
9.6¢ 9.6¢ 7.9¢ $62.05K 730.6K

Buyers (Bids)

No. Vol. Price($)
1 11625 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.8¢ 127000 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
VIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.